Presage Biosciences’ proprietary technology platform offers a truly innovative strategy that simultaneously analyzes multiple cancer drug candidates and drug combinations within a single living tumor.
The platform heralds a new era in the drug development process, allowing partners to gain crucial decision-making data and identify synergistic drug combinations in order to advance the most promising cancer drug candidates.
The Presage platform enables the placement of multiple “threads” of candidate treatments through the skin and directly into the tumor. Such controlled localization allows for the identification of drug response directly attributable to the drug versus intrinsic cell death. These precise microdose bands provide the ability to analyze drug effects across the span of a living tumor while capturing the heterogeneity of cancer cells.